Zegerid OTC Approved, Limited To Touting Dual-Ingredient Formula For Now
This article was originally published in The Tan Sheet
Executive Summary
Merck's Schering-Plough Consumer HealthCare Products division will launchZegerid OTC in the first half of 2010 as the first dual-ingredient OTC proton pump inhibitor